Triumeq 600 mg/1
abacavir sulfate, dolutegravir sodium, lamivudine · TABLET, FILM COATED · ViiV Healthcare Company
No Recall History
Plain English
Triumeq is a tablet, film coated containing abacavir sulfate, dolutegravir sodium, lamivudine at 600 mg/1, taken oral. Manufactured by ViiV Healthcare Company.
Key Facts
- Brand Name
- Triumeq
- Generic Name
- abacavir sulfate, dolutegravir sodium, lamivudine
- NDC Code (Product)
49702-231- Manufacturer
- ViiV Healthcare Company
- Strength
- 600 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA205551
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 08/22/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Triumeq used for?
Triumeq contains abacavir sulfate, dolutegravir sodium, lamivudine. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Triumeq a controlled substance?
Triumeq is not classified as a controlled substance by the DEA.
What is the generic name for Triumeq?
The generic name for Triumeq is abacavir sulfate, dolutegravir sodium, lamivudine. There are 1 other brand versions of abacavir sulfate, dolutegravir sodium, lamivudine.
What is the NDC code for Triumeq 600 mg/1?
The NDC (National Drug Code) for Triumeq 600 mg/1 is 49702-231, listed by ViiV Healthcare Company.